Medtronic has recalled the TurboHawk Plus directional atherectomy system, used in the peripheral arteries, due to the risk of catheter-tip damage during use, the US Food and Drug Administration ...

Medtronic Plc (NYSE: MDT) has initiated a voluntary recall to customers related to the risk associated with tip damage caused by guidewire prolapse in its 6 French (6Fr) TurboHawk Plus Directional ...

Medtronic and the FDA are expanding the reach of a Class I recall handed down in January for the medtech giant’s catheter designed to clear out clogged arteries. The previous recall covered more than ...

Editor's note: In an earlier version of this story, TurboHawk was misspelled. MD+DI regrets the error. Earlier this year, Medtronic recalled its HawkOne Directional ...

Study Confirms Effectiveness of Directional Atherectomy with SilverHawk ™ and TurboHawk ™ Devices as a Frontline Therapy when Treating PAD LAS VEGAS--(BUSINESS WIRE)-- Covidien (NYSE:COV), a leading ...

Starting this month, doctors will have a new tool available in treating peripheral artery disease. But one doctor at University Medical Center got to test the equipment before its wide release. Dr.

Medtronic has recalled 686 TurboHawk Plus Directional Atherectomy Systems because there is a risk that the guidewire within the catheter may move downward or prolapse during use, which may damage the ...

Study Confirms Effectiveness of Directional Atherectomy with SilverHawk ™ and TurboHawk ™ Devices as a Frontline Therapy when Treating PAD DEFINITIVE LE study confirms that directional atherectomy ...

LAS VEGAS--(BUSINESS WIRE)-- Covidien (NYS: COV) , a leading global provider of healthcare products, today announced final 12-month results from its DEFINITIVE LE (Determination of Effectiveness of ...